Journal of Clinical Oncology, Vol 15, 139-147, Copyright © 1997 by American Society of Clinical Oncology

ARTICLES

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery

D Caillot, O Casasnovas, A Bernard, JF Couaillier, C Durand, B Cuisenier, E Solary, F Piard, T Petrella, A Bonnin, G Couillault, M Dumas and H Guy
Department of Clinical Hematology, Centre Hospitalier Regional Universitaire, Hopital Le Bocage, Dijon, France.

PURPOSE: The prognosis of invasive pulmonary aspergillosis (IPA) occurring in neutropenic patients remains poor. We studied whether new strategies for early diagnosis could improve outcome in these patients. PATIENTS AND METHODS: Twenty-three histologically proven and 14 highly probable IPAs in 37 hematologic patients (neutropenic in 36) were analyzed retrospectively. RESULTS: The most frequent clinical signs associated with IPA were cough (92%), chest pain (76%), and hemoptysis (54%). Bronchoalveolar lavage (BAL) was positive in 22 of 32 cases. Aspergillus antigen test was positive in 83% of cases when tested on BAL fluid. Since October 1991, early thoracic computed tomographic (CT) scans were systematically performed in febrile neutropenic patients with pulmonary x-ray infiltrates. This approach allowed us to recognize suggestive CT halo signs in 92% of patients, compared with 13% before this date, and the mean time to IPA diagnosis was reduced dramatically from 7 to 1.9 days. Among 36 assessable patients, 10 failed to respond (amphotericin B [AmB] plus fluorocytosyne, n = 2; itraconazole + AmB, n = 8) and died of aspergillosis. Twenty-six patients were cured or improved by antifungal treatment (itraconazole with or without AmB, n = 22; voriconazole, n = 4). In 15 of 16 cases, surgical resection was combined successfully with medical treatment. Achievement of hematologic response, early diagnosis, unilateral pulmonary involvement, and highest level of fibrinogen value < 9 g/L were associated with better outcome. CONCLUSION: In febrile neutropenic patients, systematic CT scan allows earlier diagnosis of IPA. Early antifungal treatment, combined with surgical resection if necessary, improves IPA prognosis dramatically in these patients.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				N. P. Wiederhold, C. R. Thornton, L. K. Najvar, W. R. Kirkpatrick, R. Bocanegra, and T. F. Patterson Comparison of Lateral Flow Technology and Galactomannan and (1->3)-{beta}-D-Glucan Assays for Detection of Invasive Pulmonary Aspergillosis Clin. Vaccine Immunol., December 1, 2009; 16(12): 1844 - 1846. [Abstract] [Full Text] [PDF]

				S Wilson, R Grundy, and H Vyas Investigation and management of a child who is immunocompromised and neutropoenic with pulmonary infiltrates Arch. Dis. Child. Ed. Pract., October 1, 2009; 94(5): 129 - 137. [Full Text] [PDF]

				J. E. Bennett Management of mycoses in neutropenic patients: a brief history, 1960-2008 J. Antimicrob. Chemother., May 1, 2009; 63(suppl_1): i23 - i26. [Abstract] [Full Text] [PDF]

				P. E. Verweij and J. Maertens Moulds: diagnosis and treatment J. Antimicrob. Chemother., May 1, 2009; 63(suppl_1): i31 - i35. [Abstract] [Full Text] [PDF]

				B. H. Segal Aspergillosis N. Engl. J. Med., April 30, 2009; 360(18): 1870 - 1884. [Full Text] [PDF]

				P U Dalal Non-metastatic manifestations of cancer in the chest Imaging, September 1, 2008; 20(3): 194 - 204. [Abstract] [Full Text] [PDF]

				E. Zandijk, A. Mewis, K. Magerman, and R. Cartuyvels False-Positive Results by the Platelia Aspergillus Galactomannan Antigen Test for Patients Treated with Amoxicillin-Clavulanate Clin. Vaccine Immunol., July 1, 2008; 15(7): 1132 - 1133. [Abstract] [Full Text] [PDF]

				E. M. Marom, A. M. Holmes, J. F. Bruzzi, M. T. Truong, P. J. O'Sullivan, and D. P. Kontoyiannis Imaging of Pulmonary Fusariosis in Patients with Hematologic Malignancies Am. J. Roentgenol., June 1, 2008; 190(6): 1605 - 1609. [Abstract] [Full Text] [PDF]

				A. Burgos, T. E. Zaoutis, C. C. Dvorak, J. A. Hoffman, K. M. Knapp, J. J. Nania, P. Prasad, and W. J. Steinbach Pediatric Invasive Aspergillosis: A Multicenter Retrospective Analysis of 139 Contemporary Cases Pediatrics, May 1, 2008; 121(5): e1286 - e1294. [Abstract] [Full Text] [PDF]

				N. P. Wiederhold, L. K. Najvar, A. C. Vallor, W. R. Kirkpatrick, R. Bocanegra, D. Molina, M. Olivo, J. R. Graybill, and T. F. Patterson Assessment of Serum (1->3)-{beta}-D-Glucan Concentration as a Measure of Disease Burden in a Murine Model of Invasive Pulmonary Aspergillosis Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1176 - 1178. [Abstract] [Full Text] [PDF]

				M. Ellis, B. al-Ramadi, M. Finkelman, U. Hedstrom, J. Kristensen, H. Ali-Zadeh, and L. Klingspor Assessment of the clinical utility of serial {beta}-D-glucan concentrations in patients with persistent neutropenic fever J. Med. Microbiol., March 1, 2008; 57(3): 287 - 295. [Abstract] [Full Text] [PDF]

				P. Samarakoon and A. Soubani Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature Chronic Respiratory Disease, February 1, 2008; 5(1): 19 - 27. [Abstract] [PDF]

				R. E Greene, J. Mauskopf, C. S. Roberts, T. Zyczynski, and H. T. Schlamm Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis Am. J. Health Syst. Pharm., December 15, 2007; 64(24): 2561 - 2568. [Abstract] [Full Text] [PDF]

				P. Bulpa, A. Dive, and Y. Sibille Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease Eur. Respir. J., October 1, 2007; 30(4): 782 - 800. [Abstract] [Full Text] [PDF]

				O.S. Zmeili and A.O. Soubani Pulmonary aspergillosis: a clinical update QJM, June 1, 2007; 100(6): 317 - 334. [Abstract] [Full Text] [PDF]

				C. J. Clancy, R. A. Jaber, H. L. Leather, J. R. Wingard, B. Staley, L. J. Wheat, C. L. Cline, K. H. Rand, D. Schain, M. Baz, et al. Bronchoalveolar Lavage Galactomannan in Diagnosis of Invasive Pulmonary Aspergillosis among Solid-Organ Transplant Recipients J. Clin. Microbiol., June 1, 2007; 45(6): 1759 - 1765. [Abstract] [Full Text] [PDF]

				M. Ellis, C. Frampton, J. Joseph, H. Alizadeh, J. Kristensen, A. Hauggaard, and F. Shammas An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy. J. Med. Microbiol., October 1, 2006; 55(Pt 10): 1357 - 1365. [Abstract] [Full Text] [PDF]

				D. A. Enoch, H. A. Ludlam, and N. M. Brown Invasive fungal infections: a review of epidemiology and management options. J. Med. Microbiol., July 1, 2006; 55(Pt 7): 809 - 818. [Abstract] [Full Text] [PDF]

				I A Hassan, P Critten, B Isalska, and D W Denning Audit of laboratory mycology services for the management of patients with fungal infections in the northwest of England. J. Clin. Pathol., July 1, 2006; 59(7): 759 - 763. [Abstract] [Full Text] [PDF]

				B. H. Segal and T. J. Walsh Current Approaches to Diagnosis and Treatment of Invasive Aspergillosis Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 707 - 717. [Abstract] [Full Text] [PDF]

				C. A. Kauffman Fungal Infections Proceedings of the ATS, March 1, 2006; 3(1): 35 - 40. [Abstract] [Full Text] [PDF]

				A. Glasmacher, O. Cornely, A. J. Ullmann, U. Wedding, H. Bodenstein, H. Wandt, C. Boewer, R. Pasold, H.-H. Wolf, M. Hanel, et al. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia J. Antimicrob. Chemother., February 1, 2006; 57(2): 317 - 325. [Abstract] [Full Text] [PDF]

				E. Bouza, J. Guinea, T. Pelaez, J. Perez-Molina, L. Alcala, and P. Munoz Workload Due to Aspergillus fumigatus and Significance of the Organism in the Microbiology Laboratory of a General Hospital J. Clin. Microbiol., May 1, 2005; 43(5): 2075 - 2079. [Abstract] [Full Text] [PDF]

				P. Matt, F. Bernet, J. Habicht, F. Gambazzi, A. Gratwohl, H.-R. Zerkowski, and M. Tamm Predicting Outcome After Lung Resection for Invasive Pulmonary Aspergillosis in Patients With Neutropenia Chest, December 1, 2004; 126(6): 1783 - 1788. [Abstract] [Full Text] [PDF]

				M. Cuenca-Estrella Combinations of antifungal agents in therapy-what value are they? J. Antimicrob. Chemother., November 1, 2004; 54(5): 854 - 869. [Abstract] [Full Text] [PDF]

				A. Y. Peleg and M. L. Woods Continuous and 4 h infusion of amphotericin B: a comparative study involving high-risk haematology patients J. Antimicrob. Chemother., October 1, 2004; 54(4): 803 - 808. [Abstract] [Full Text] [PDF]

				L. de Aguirre, S. F. Hurst, J. S. Choi, J. H. Shin, H. P. Hinrikson, and C. J. Morrison Rapid Differentiation of Aspergillus Species from Other Medically Important Opportunistic Molds and Yeasts by PCR-Enzyme Immunoassay J. Clin. Microbiol., August 1, 2004; 42(8): 3495 - 3504. [Abstract] [Full Text] [PDF]

				R. M. Kotloff, V. N. Ahya, and S. W. Crawford Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 22 - 48. [Abstract] [Full Text] [PDF]

				M. Kawazu, Y. Kanda, Y. Nannya, K. Aoki, M. Kurokawa, S. Chiba, T. Motokura, H. Hirai, and S. Ogawa Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1->3)-{beta}-D-Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders J. Clin. Microbiol., June 1, 2004; 42(6): 2733 - 2741. [Abstract] [Full Text] [PDF]

				C. E. O'Sullivan, M. Kasai, A. Francesconi, V. Petraitis, R. Petraitiene, A. M. Kelaher, A. A. Sarafandi, and T. J. Walsh Development and Validation of a Quantitative Real-Time PCR Assay Using Fluorescence Resonance Energy Transfer Technology for Detection of Aspergillus fumigatus in Experimental Invasive Pulmonary Aspergillosis J. Clin. Microbiol., December 1, 2003; 41(12): 5676 - 5682. [Abstract] [Full Text] [PDF]

				T M Wah, H A Moss, R J H Robertson, and D L Barnard Pulmonary complications following bone marrow transplantation Br. J. Radiol., June 1, 2003; 76(906): 373 - 379. [Abstract] [Full Text] [PDF]

				B. Spiess, D. Buchheidt, C. Baust, H. Skladny, W. Seifarth, U. Zeilfelder, C. Leib-Mosch, H. Morz, and R. Hehlmann Development of a LightCycler PCR Assay for Detection and Quantification of Aspergillus fumigatus DNA in Clinical Samples from Neutropenic Patients J. Clin. Microbiol., May 1, 2003; 41(5): 1811 - 1818. [Abstract] [Full Text] [PDF]

				J.M. Habicht, M. Preiss, J. Passweg, P. Dalquen, P. Matt, H. Adler, R. Frei, and H.-R. Zerkowski Invasive pulmonary aspergillosis: effects of early resection in a neutropenic rat model Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 728 - 732. [Abstract] [Full Text] [PDF]

				A. O. Soubani and P. H. Chandrasekar The Clinical Spectrum of Pulmonary Aspergillosis* Chest, June 1, 2002; 121(6): 1988 - 1999. [Abstract] [Full Text] [PDF]

				M. J. Becker, S. de Marie, M. H. A. M. Fens, W. C. J. Hop, H. A. Verbrugh, and I. A. J. M. Bakker-Woudenberg Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response J. Antimicrob. Chemother., May 1, 2002; 49(5): 813 - 820. [Abstract] [Full Text] [PDF]

				R. Herbrecht, V. Letscher-Bru, C. Oprea, B. Lioure, J. Waller, F. Campos, O. Villard, K.-L. Liu, S. Natarajan-Ame, P. Lutz, et al. AspergillusGalactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients J. Clin. Oncol., April 1, 2002; 20(7): 1898 - 1906. [Abstract] [Full Text] [PDF]

				R. Petraitiene, V. Petraitis, A. H. Groll, T. Sein, R. L. Schaufele, A. Francesconi, J. Bacher, N. A. Avila, and T. J. Walsh Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia Antimicrob. Agents Chemother., January 1, 2002; 46(1): 12 - 23. [Abstract] [Full Text] [PDF]

				Acute myeloid leukaemia with tell-tale computed tomography scans Postgrad. Med. J., November 1, 2001; 77(913): 736a - 736. [Full Text] [PDF]

				K. Al-Kattan, M. Ashour, W. Hajjar, M. Salah El Din, M. Fouda, and A. Al Bakry Surgery for pulmonary aspergilloma in post-tuberculous vs. immuno-compromised patients Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 728 - 733. [Abstract] [Full Text] [PDF]

				T. Kudoh, N. Suzuki, N. Hatakeyama, N. Mizue, T. Hori, T. Oda, J. Watanabe, M. Imamura, and S. Chiba Successful Unrelated Cord Blood Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Pulmonary Aspergillosis Treated by Anti-fungal Therapy, Granulocyte Colony-stimulating Factor-mobilized Granulocytes and Surgical Resection: Case Report Jpn. J. Clin. Oncol., June 1, 2001; 31(6): 290 - 293. [Abstract] [Full Text] [PDF]

				J. Maertens, J. Verhaegen, K. Lagrou, J. Van Eldere, and M. Boogaerts Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation Blood, March 15, 2001; 97(6): 1604 - 1610. [Abstract] [Full Text] [PDF]

				U. Eriksson, B. Seifert, and A. Schaffner Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial BMJ, March 10, 2001; 322(7286): 579 - 579. [Abstract] [Full Text]

				R. Petraitiene, V. Petraitis, A. H. Groll, T. Sein, S. Piscitelli, M. Candelario, A. Field-Ridley, N. Avila, J. Bacher, and T. J. Walsh Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia Antimicrob. Agents Chemother., March 1, 2001; 45(3): 857 - 869. [Abstract] [Full Text] [PDF]

				M. Nucci, T. Akiti, G. Barreiros, F. Silveira, S. G. Revankar, D. A. Sutton, and T. F. Patterson Nosocomial Fungemia Due to Exophiala jeanselmei var. jeanselmei and a Rhinocladiella Species: Newly Described Causes of Bloodstream Infection J. Clin. Microbiol., February 1, 2001; 39(2): 514 - 518. [Abstract] [Full Text] [PDF]

				L.P. Nicod, J-C. Pache, and N. Howarth Fungal infections in transplant recipients Eur. Respir. J., January 1, 2001; 17(1): 133 - 140. [Abstract] [Full Text] [PDF]

				F. Reichenberger, J.M. Habicht, A. Gratwohl, and M. Tamm Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients Eur. Respir. J., January 1, 2001; 19(4): 743 - 755. [Abstract] [Full Text] [PDF]

				D. Caillot, J.-F. Couaillier, A. Bernard, O. Casasnovas, D. W. Denning, L. Mannone, J. Lopez, G. Couillault, F. Piard, O. Vagner, et al. Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With Neutropenia J. Clin. Oncol., January 1, 2001; 19(1): 253 - 259. [Abstract] [Full Text] [PDF]

				K. M. Sullivan, C. A. Dykewicz, D. L. Longworth, M. Boeckh, L. R. Baden, R. H. Rubin, and K. A. Sepkowitz Preventing Opportunistic Infections After Hematopoietic Stem Cell Transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and Beyond Hematology, January 1, 2001; 2001(1): 392 - 421. [Abstract] [Full Text] [PDF]

				N. Singh Invasive mycoses in organ transplant recipients: controversies in prophylaxis and management J. Antimicrob. Chemother., June 1, 2000; 45(6): 749 - 755. [Full Text] [PDF]

				J. M. Habicht, J. Passweg, T. Kuhne, K. Leibundgut, and H.-R. Zerkowski SUCCESSFUL LOCAL EXCISION AND LONG-TERM SURVIVAL FOR INVASIVE PULMONARY ASPERGILLOSIS DURING NEUTROPENIA AFTER BONE MARROW TRANSPLANTATION J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1286 - 1287. [Full Text] [PDF]

				C. Mayaud and J. Cadranel A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host Thorax, June 1, 2000; 55(6): 511 - 517. [Full Text]

				S. F. Hurst, G. H. Reyes, D. W. McLaughlin, E. Reiss, and C. J. Morrison Comparison of Commercial Latex Agglutination and Sandwich Enzyme Immunoassays with a Competitive Binding Inhibition Enzyme Immunoassay for Detection of Antigenemia and Antigenuria in a Rabbit Model of Invasive Aspergillosis Clin. Vaccine Immunol., May 1, 2000; 7(3): 477 - 485. [Abstract] [Full Text] [PDF]

				S. Perea, G. J. Pennick, A. Modak, A. W. Fothergill, D. A. Sutton, D. J. Sheehan, and M. G. Rinaldi Comparison of High-Performance Liquid Chromatographic and Microbiological Methods for Determination of Voriconazole Levels in Plasma Antimicrob. Agents Chemother., May 1, 2000; 44(5): 1209 - 1213. [Abstract] [Full Text] [PDF]

				E C M Williamson, D A Oliver, E M Johnson, A B M Foot, D I Marks, and D W Warnock Aspergillus antigen testing in bone marrow transplant recipients J. Clin. Pathol., May 1, 2000; 53(5): 362 - 366. [Abstract] [Full Text] [PDF]

				B. F. F. Chumpitazi, C. Pinel, B. Lebeau, P. Ambroise-Thomas, and R. Grillot Aspergillus fumigatus Antigen Detection in Sera from Patients at Risk for Invasive Aspergillosis J. Clin. Microbiol., January 1, 2000; 38(1): 438 - 443. [Abstract] [Full Text] [PDF]

				H. Skladny, D. Buchheidt, C. Baust, F. Krieg-Schneider, W. Seifarth, C. Leib-Mosch, and R. Hehlmann Specific Detection of Aspergillus Species in Blood and Bronchoalveolar Lavage Samples of Immunocompromised Patients by Two-Step PCR J. Clin. Microbiol., December 1, 1999; 37(12): 3865 - 3871. [Abstract] [Full Text] [PDF]

				D. W. Denning and P. Warn Dose Range Evaluation of Liposomal Nystatin and Comparisons with Amphotericin B and Amphotericin B Lipid Complex in Temporarily Neutropenic Mice Infected with an Isolate of Aspergillus fumigatus with Reduced Susceptibility to Amphotericin B Antimicrob. Agents Chemother., November 1, 1999; 43(11): 2592 - 2599. [Abstract] [Full Text] [PDF]

				J. M. Habicht, F. Reichenberger, A. Gratwohl, H.-R. Zerkowski, and M. Tamm Surgical aspects of resection for suspected invasive pulmonary fungal infection in neutropenic patients Ann. Thorac. Surg., August 1, 1999; 68(2): 321 - 325. [Abstract] [Full Text] [PDF]

				S. Schwartz, G. Behre, V. Heinemann, H. Wandt, E. Schilling, M. Arning, A. Trittin, W.V. Kern, O. Boenisch, D. Bosse, et al. Aerosolized Amphotericin B Inhalations as Prophylaxis of Invasive Aspergillus Infections During Prolonged Neutropenia: Results of a Prospective Randomized Multicenter Trial Blood, June 1, 1999; 93(11): 3654 - 3661. [Abstract] [Full Text] [PDF]

				J.-P. Latge Aspergillus fumigatus and Aspergillosis Clin. Microbiol. Rev., April 1, 1999; 12(2): 310 - 350. [Abstract] [Full Text] [PDF]

				F. REICHENBERGER, J. HABICHT, A. KAIM, P. DALQUEN, F. BERNET, R. SCHLAPFER, P. STULZ, A. P. PERRUCHOUD, A. TICHELLI, A. GRATWOHL, et al. Lung Resection for Invasive Pulmonary Aspergillosis in Neutropenic Patients with Hematologic Diseases Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 885 - 890. [Abstract] [Full Text] [PDF]

				C. T. Salerno, D. W. Ouyang, T. S. Pederson, D. M. Larson, J. P. Shake, E. M. Johnson, and M. A. Maddaus Surgical Therapy for Pulmonary Aspergillosis in Immunocompromised Patients Ann. Thorac. Surg., May 1, 1998; 65(5): 1415 - 1419. [Abstract] [Full Text] [PDF]

				O. Baron, B. Guillaume, P. Moreau, P. Germaud, P. Despins, A. Y. De Lajartre, J. L. Michaud, S. :, and W. A. Fry Aggressive surgical management in localized pulmonary mycotic and nonmycotic infections for neutropenic patients with acute leukemia: Report of eighteen cases J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 63 - 69. [Abstract] [Full Text] [PDF]

				A. Bernard, D. Caillot, J. F. Couaillier, O. Casasnovas, H. Guy, and J. P. Favre Surgical Management of Invasive Pulmonary Aspergillosis in Neutropenic Patients Ann. Thorac. Surg., November 1, 1997; 64(5): 1441 - 1447. [Abstract] [Full Text]